TELO — Telomir Pharmaceuticals Share News
0.000.00%
Last trade - 00:00Brief: Telomir Pharmaceuticals Demonstrates Broad Tumor Cell Mortality In Human Triple-Negative Breast Cancer Models
Brief: Telomir Pharmaceuticals Telomir-1 Significantly Reduced Tumor Growth And Metastases
Brief: Telomir Pharmaceuticals Reports New Data Showing Telomir-1 Resets Cancer’S “Kill-And-Clean” Defense Systems In An Aggressive Prostate Cancer Model
U.S. STOCKS ON THE MOVE-InterDigital, Scholar Rock, Live Nation
U.S. STOCKS ON THE MOVE-Whirlpool, IREN, Cidara
Telomir Pharmaceuticals climbs on promising breast cancer therapy data
Brief: Telomir Pharmaceuticals Telomir-1 Selectively Kills Aggressive Triple-Negative Breast Cancer Cells
U.S. STOCKS ON THE MOVE- Applovin, Ford Motor, Alto Neuroscience
U.S. STOCKS ON THE MOVE- Veeva Systems, Dell, Nano Nuclear
U.S. STOCKS ON THE MOVE-Constellation Brands, Intercontinental Exchange, IBM
Telomir Pharmaceuticals climbs on promising cancer therapy data
Brief: Telomir Pharmaceuticals- In Vitro Data Shows Telomir-1 Targets Additional Histone Demethylases - SEC Filing
Brief: Telomir Pharmaceuticals Inc - Telomir-1 Reverses Cdkn2a Gene Silencing - SEC Filing
U.S. STOCKS ON THE MOVE-Victoria's Secret, Copper miners, Dell
U.S. STOCKS ON THE MOVE-Victoria's Secret, Copper miners, Dell
U.S. STOCKS ON THE MOVE-Dollar General, Best Buy, Teva Pharmaceutical
U.S. STOCKS ON THE MOVE-CrowdStrike, Cheniere Energy, Outlook Therapeutics
Telomir Pharma surges on early data for epigenetic drug
Brief: Telomir Pharmaceuticals Inc Reports In Vitro Data On Telomir-1 As Epigenetic Therapy